Castleview Partners’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Sell
9,248
-82
-0.9% -$4.87K 0.25% 97
2026
Q1
$468K Buy
9,330
+3,455
+59% +$184K 0.24% 99
2025
Q4
$322K Sell
5,875
-2,322
-28% -$126K 0.16% 132
2025
Q3
$440K Sell
8,197
-764
-9% -$38.9K 0.24% 87
2025
Q2
$432K Buy
+8,961
New +$382K 0.28% 87
2023
Q2
Sell
-1,347
Closed -$34.3K 698
2023
Q1
$34.3K Sell
1,347
-5
-0.4% -$118 0.03% 297
2022
Q4
$28.5K Hold
1,352
0.03% 275
2022
Q3
$29K Buy
1,352
+919
+212% +$22K 0.03% 299
2022
Q2
$39.7K Sell
433
-922
-68% -$23.1K 0.03% 332
2022
Q1
$40K Sell
1,355
-60,251
-98% -$1.8M 0.02% 372
2021
Q4
$1.78K Buy
+61,606
New +$2.13M 0.01% 298

Other funds holding FBCG

Castleview Partners's FBCG Position: Q2 2026 in Review

Castleview Partners reduced its Fidelity Blue Chip Growth ETF (FBCG) stake by 0.88% in Q2 2026, selling an estimated $4.87K and leaving 9,248 shares worth $574K. The position accounts for 0.25% of the portfolio, ranked #97.

Castleview Partners first reported a position in FBCG in Q4 2021 and has held it in 11 quarters since. 145 funds tracked by Wall St. Rank hold FBCG as of Q2 2026.

  • Castleview Partners held 9,248 shares of Fidelity Blue Chip Growth ETF worth $574K as of Q2 2026.
  • Castleview Partners sold 82 Fidelity Blue Chip Growth ETF shares in Q2 2026, an estimated $4.87K.
  • Fidelity Blue Chip Growth ETF made up 0.25% of Castleview Partners's portfolio in Q2 2026, its #97 holding.
  • Castleview Partners first reported a position in Fidelity Blue Chip Growth ETF in Q4 2021 and has held it in 11 quarters since.
  • 145 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.